Georgetown University's Lombardi Comprehensive Cancer Center researchers have identified a new way to reprogram T cells, ...
The deal is the second Chinese oncology pact in as many weeks for AbbVie, which also committed $175 million for a ...
US pharma major AbbVie and China’s RemeGen today announced an exclusive licensing agreement for the development, ...
AbbVie and RemeGen are the first companies to announce a deal at the J.P Morgan Healthcare Conference 2026, with more deals ...
AbbVie (NYSE: ABBV) and RemeGen today announced an exclusive licensing agreement for the development, manufacturing and commercialization of RC148, a novel investigational Programmed Cell Death-1 ...
ScienceAlert on MSN
Body resurrects cells marked for death, solving a 50-year mystery
When tissue is severely damaged, surviving cells can respond in a concentrated burst of biological repair known as ...
Zymeworks (ZYME) posts strong Phase 3 Ziihera data in HER2+ GEA and eyes up to $440M in milestones plus royalties—read the ...
A study published in the International Journal of Molecular Sciences reports that a cannabis extract reduced cell growth, ...
A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...
After an ICE agent fatally shot Renee Good in Minneapolis on Wednesday, response has divided along partisan lines over what ...
Pancreatic cancer is notoriously hard to treat, often resisting therapies that target its most common mutations. Researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback